{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:02:47Z","timestamp":1791928967904,"version":"4.3.4"},"reference-count":67,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"5","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2026,5,21]]},"DOI":"10.1167\/iovs.67.5.61","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T13:30:42Z","timestamp":1779370242000},"page":"61","source":"Crossref","is-referenced-by-count":0,"title":["Development of Miniprotein Binders to Inhibit VEGF-Induced Corneal Neovascularization"],"prefix":"10.1167","volume":"67","author":[{"given":"Nana Aisha","family":"Adams","sequence":"first","affiliation":[{"name":"College of Optometry, University of Houston, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda M.","family":"Alaniz","sequence":"additional","affiliation":[{"name":"College of Optometry, University of Houston, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahi Nandini","family":"Wuppukondur","sequence":"additional","affiliation":[{"name":"College of Optometry, University of Houston, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Schill","sequence":"additional","affiliation":[{"name":"College of Optometry, University of Houston, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaccheaus O.","family":"Alabi","sequence":"additional","affiliation":[{"name":"Department of Biology and Biochemistry, University of Houston, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"\u015een","sequence":"additional","affiliation":[{"name":"Department of Biology and Biochemistry, University of Houston, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivien J.","family":"Coulson-Thomas","sequence":"additional","affiliation":[{"name":"College of Optometry, University of Houston, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarsis F.","family":"Gesteira","sequence":"additional","affiliation":[{"name":"College of Optometry, University of Houston, Houston, Texas, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"108457","DOI":"10.1016\/j.exer.2021.108457","article-title":"Corneal angiogenic privilege and its failure","volume":"204","author":"Di Zazzo","year":"2021","journal-title":"Exp Eye Res"},{"issue":"4","key":"bib2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"bib3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"bib4","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF)-key factor in normal and pathological angiogenesis","volume":"59","author":"Stanca Melincovici","year":"2018","journal-title":"Rom J Morphol Embryol"},{"issue":"4935","key":"bib5","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.2479986","article-title":"Vascular endothelial growth factor is a secreted angiogenic mitogen","volume":"246","author":"Leung","year":"1989","journal-title":"Science"},{"issue":"1","key":"bib7","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12886-018-0785-3","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials","volume":"18","author":"Nguyen","year":"2018","journal-title":"BMC Ophthalmol."},{"issue":"3","key":"bib8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.51329\/mehdiophthal1526","article-title":"Anti-vascular endothelial growth factor therapies in ophthalmology","volume":"14","author":"Koksaldi","year":"2025","journal-title":"Med Hypothesis Discov Innov Ophthalmol"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jconrel.2021.04.008","article-title":"Challenges and strategies for the delivery of biologics to the cornea","volume":"333","author":"Wels","year":"2021","journal-title":"J Control Release"},{"issue":"1","key":"bib10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1365-2249.2002.01808.x","article-title":"Penetration of engineered antibody fragments into the eye","volume":"128","author":"Thiel","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"bib11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.survophthal.2010.08.006","article-title":"Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease","volume":"56","author":"Tolentino","year":"2011","journal-title":"Surv Ophthalmol"},{"issue":"12","key":"bib12","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.2174\/1389450121666200319111710","article-title":"Anti-VEGF treatment in corneal diseases","volume":"21","author":"Giannaccare","year":"2020","journal-title":"Curr Drug Targets"},{"issue":"7674","key":"bib13","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nature23912","article-title":"Massively parallel de novo protein design for targeted therapeutics","volume":"550","author":"Chevalier","year":"2017","journal-title":"Nature"},{"issue":"7910","key":"bib14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-022-04654-9","article-title":"Design of protein-binding proteins from the target structure alone","volume":"605","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/978-1-0716-1855-4","article-title":"Computational design of miniprotein binders","volume":"2405","author":"Bouchiba","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"4","key":"bib16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.tibs.2019.12.008","article-title":"Miniproteins as a powerful modality in drug development","volume":"45","author":"Crook","year":"2020","journal-title":"Trends Biochem Sci"},{"issue":"4","key":"bib17","first-page":"155","article-title":"The emerging role of new protein scaffold-based agents for treatment of cancer","volume":"10","author":"Weidle","year":"2013","journal-title":"Cancer Genomics Proteomics"},{"issue":"4","key":"bib18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1021\/acsbiomedchemau.2c00008","article-title":"Design and engineering of miniproteins","volume":"2","author":"Ozga","year":"2022","journal-title":"ACS Bio Med Chem Au"},{"issue":"1","key":"bib19","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41392-024-02010-z","article-title":"Miniproteins may have a big impact: new therapeutics for autoimmune diseases and beyond","volume":"9","author":"Asada","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"7976","key":"bib20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"issue":"11","key":"bib21","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/biom15111587","article-title":"De novo design of high-affinity HER2-targeting protein minibinders","volume":"15","author":"Zhao","year":"2025","journal-title":"Biomolecules"},{"issue":"9","key":"bib22","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0969-2126(98)00116-6","article-title":"VEGF and the Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 \u00c5 resolution and mutational analysis of the interface","volume":"6","author":"Muller","year":"1998","journal-title":"Structure"},{"issue":"D1","key":"bib23","doi-asserted-by":"publisher","first-page":"D464","DOI":"10.1093\/nar\/gky1004","article-title":"RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy","volume":"47","author":"Burley","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"bib24","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1074\/jbc.271.10.5638","article-title":"Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors","volume":"271","author":"Keyt","year":"1996","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"bib25","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s13361-017-1601-7","article-title":"Mapping the binding interface of VEGF and a monoclonal antibody Fab-1 fragment with fast photochemical oxidation of proteins (FPOP) and mass spectrometry","volume":"28","author":"Zhang","year":"2017","journal-title":"J Am Soc Mass Spectrom"},{"issue":"5","key":"bib26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/S0092-8674(00)80456-0","article-title":"Crystal structure at 1.7 \u00c5 resolution f VEGF in complex with domain 2 of the Fit-1 receptor","volume":"91","author":"Wiesmann","year":"1997","journal-title":"Cell"},{"issue":"1","key":"bib27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1247\/csf.26.25","article-title":"Structure and function of VEGF\/VEGF-receptor system involved in angiogenesis","volume":"26","author":"Shibuya","year":"2001","journal-title":"Cell Struct Funct"},{"issue":"6615","key":"bib28","first-page":"49","article-title":"Robust deep learning\u2013based protein sequence design using ProteinMPNN","volume":"378","author":"Dauparas","year":"2022","journal-title":"Science (1979)"},{"issue":"1","key":"bib29","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1038\/s41467-023-38328-5","article-title":"Improving de novo protein binder design with deep learning","volume":"14","author":"Bennett","year":"2023","journal-title":"Nat Commun"},{"issue":"7873","key":"bib30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"1","key":"bib31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12934-020-01502-1","article-title":"Effective production of human growth factors in Escherichia coli by fusing with small protein 6HFh8","volume":"20","author":"Kim","year":"2021","journal-title":"Microb Cell Fact"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molstruc.2014.03.009","article-title":"MicroScale thermophoresis: interaction analysis and beyond","volume":"1077","author":"Jerabek-Willemsen","year":"2014","journal-title":"J Mol Struct"},{"issue":"1","key":"bib33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3390\/cells11010178","article-title":"Isolation and propagation of human corneal stromal keratocytes for tissue engineering and cell therapy","volume":"11","author":"Yusoff","year":"2022","journal-title":"Cells"},{"issue":"9","key":"bib34","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/biom13091385","article-title":"ROS-mediated fragmentation alters the effects of hyaluronan on corneal epithelial wound healing","volume":"13","author":"Lin","year":"2023","journal-title":"Biomolecules"},{"issue":"4","key":"bib35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1167\/tvst.12.4.13","article-title":"Characterization of the molecular weight of hyaluronan in eye products using a novel method of size exclusion high-pressure liquid chromatography","volume":"12","author":"Nguyen","year":"2023","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"bib36","doi-asserted-by":"publisher","first-page":"11568","DOI":"10.1038\/s41598-020-67289-8","article-title":"Angiogenesis analyzer for ImageJ \u2014 a comparative morphometric analysis of \u201cEndothelial Tube Formation Assay\u201d and \u201cFibrin Bead Assay","volume":"10","author":"Carpentier","year":"2020","journal-title":"Sci Rep"},{"issue":"86","key":"bib37","first-page":"51159","article-title":"An alkali-burn injury model of corneal neovascularization in the mouse","author":"Anderson","year":"2014","journal-title":"J Vis Exp"},{"issue":"3","key":"bib38","doi-asserted-by":"publisher","first-page":"103906","DOI":"10.1016\/j.xpro.2025.103906","article-title":"Protocol for immunofluorescent staining, high-resolution imaging, and spatial projection of Schlemm's canal in mouse whole-mount corneal limbus tissue","volume":"6","author":"Wang","year":"2025","journal-title":"STAR Protoc"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"109125","DOI":"10.1016\/j.exer.2022.109125","article-title":"Promotion of corneal angiogenesis by sensory neuron-derived calcitonin gene-related peptide","volume":"220","author":"Zhu","year":"2022","journal-title":"Exp Eye Res"},{"issue":"14","key":"bib40","doi-asserted-by":"publisher","first-page":"7192","DOI":"10.1073\/pnas.94.14.7192","article-title":"Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding?site","volume":"94","author":"Muller","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"bib41","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.3390\/ijms22115708","article-title":"Extracellular matrix deposition and remodeling after corneal alkali burn in mice","volume":"22","author":"Mutoji","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"5","key":"bib42","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"bib43","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","article-title":"Inhibition of corneal neovascularization by topical bevacizumab (anti-VEGF) and sunitinib (anti-VEGF and anti-PDGF) in an animal model","volume":"150","author":"P\u00e9rez-Santonja","year":"2010","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"bib44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul Surf"},{"issue":"s243","key":"bib45","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2008.5144.x-i1","article-title":"Effect of VEGF blockade on corneal graft neovascularization and rejection in rats","volume":"86","author":"Rocher","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"bib46","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3109\/02713683.2011.601840","article-title":"The impact of subconjuctivally injected EGF and VEGF inhibitors on experimental corneal neovascularization in rat model","volume":"36","author":"Sener","year":"2011","journal-title":"Curr Eye Res"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.2147\/OPTH.S260302","article-title":"Effects of VEGF inhibitor conbercept on corneal neovascularization following penetrating keratoplasty in rabbit model","volume":"14","author":"Liu","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"bib48","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40662-017-0094-6","article-title":"Therapeutic approaches for corneal neovascularization","volume":"4","author":"Feizi","year":"2017","journal-title":"Eye Vis (Lond)"},{"issue":"4","key":"bib49","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/aos.15783","article-title":"Treatment burden on patients receiving intravitreal anti-VEGF for wet age-related macular degeneration","volume":"102","author":"Vinge","year":"2024","journal-title":"Acta Ophthalmol"},{"issue":"7","key":"bib50","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"issue":"12","key":"bib51","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/bjophthalmol-2014-305252","article-title":"Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD","volume":"98","author":"Avery","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"bib52","first-page":"63","article-title":"Anti-VEGF agents and the risk of arteriothrombotic events","volume":"7","author":"Zarbin","year":"2018","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"3","key":"bib53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ophtha.2020.07.062","article-title":"Risk of systemic adverse events after intravitreal bevacizumab, ranibizumab, and aflibercept in routine clinical practice","volume":"128","author":"Maloney","year":"2021","journal-title":"Ophthalmology"},{"issue":"6","key":"bib54","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3928\/23258160-20141118-07","article-title":"Response to aflibercept after frequent re-treatment with bevacizumab or ranibizumab in eyes with neovascular AMD","volume":"45","author":"Thorell","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"bib55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5935\/0004-2749.20200020","article-title":"Cost-effectiveness of anti-VEGF treatments for age-related macular degeneration: a Brazilian perspective","volume":"83","author":"Nunes","year":"2020","journal-title":"Arq Bras Oftalmol"},{"issue":"1","key":"bib56","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1002\/mef2.33","article-title":"Antiangiogenic therapy for ocular diseases: current status and challenges","volume":"2","author":"Chen","year":"2023","journal-title":"MedComm Futur Med"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.2147\/OPTH.S103443","article-title":"Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells","volume":"10","author":"Jun","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"bib58","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1167\/iovs.07-1175","article-title":"Interaction between bevacizumab and murine VEGF-A: a reassessment","volume":"49","author":"Yu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"bib59","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1167\/iovs.06-0570","article-title":"Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis","volume":"48","author":"Bock","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"bib60","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J Clin Invest"},{"key":"bib61","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"12","key":"bib62","doi-asserted-by":"publisher","first-page":"8718","DOI":"10.1167\/iovs.11-7871","article-title":"Corneal penetration of topical and subconjunctival bevacizumab","volume":"52","author":"Dastjerdi","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"bib63","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J Pharm Sci"},{"issue":"5","key":"bib64","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/jcm10050981","article-title":"Inflammatory complications of intravitreal anti-VEGF injections","volume":"10","author":"Cox","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"bib65","doi-asserted-by":"publisher","first-page":"eabq3104","DOI":"10.1126\/sciadv.abq3104","article-title":"Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment","volume":"9","author":"Shen","year":"2023","journal-title":"Sci Adv"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2019.05.034","article-title":"Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations","volume":"306","author":"Cooper","year":"2019","journal-title":"J Control Release"},{"issue":"8","key":"bib67","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s40123-025-01157-4","article-title":"Systemic effects of intravitreal anti-VEGF therapy: a review of safety across organ systems","volume":"14","author":"Banerjee","year":"2025","journal-title":"Ophthalmol Ther"},{"key":"bib6","first-page":"170","article-title":"Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives","volume-title":"Signal Transduct Target Ther","author":"Lee","year":"2025"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.5.61","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:23Z","timestamp":1791927143000},"score":1,"resource":{"primary":{"URL":"http:\/\/iovs.arvojournals.org\/article.aspx?doi=10.1167\/iovs.67.5.61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,1]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.67.5.61","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}